entertainment -WSS

entertainment

author：hotspot 2025-10-01 00:57:41 - browse：36

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Health AI: on the border between health care and tech

entertainment

WSS

Illumina slashes 2023 revenue projections yet again

Dozens dead from Maui wildfires: What we know about the victims

Timeline: How the deadly wildfires took over Maui day by day

Be careful with at

Who gets to use the title 'doctor'?

Indictment alleges Trump's ex

focus

entertainment

entertainment

Virginia high school admissions case could be legal follow

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Psychedelics group wrestles with new pharma identity

Global childhood vaccinations edge closer to pre

Moonlake's readout produced a cash windfall. Risks remain

Timeline: How the deadly wildfires took over Maui day by day

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Trump demands the U.S. pay no more for drugs than other countries … again

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

leisure time

Grail faces three suits alleging harassment, retaliation

Everything to know for the next Powerball drawing as jackpot hits $1 billion

Mark Cuban is blaming the wrong people for high drug costs

Bird flu researchers hone in on Finland’s mink farms

Involuntary treatment for addiction doesn't work

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

hotspot

entertainment

entertainment

focus